HEADER PEPTIDE BINDING PROTEIN 30-APR-20 6YX1 TITLE CRYSTAL STRUCTURE OF SHANK1 PDZ IN COMPLEX WITH A PEPTIDE-SMALL TITLE 2 MOLECULE HYBRID COMPND MOL_ID: 1; COMPND 2 MOLECULE: SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SHANK1,SOMATOSTATIN RECEPTOR-INTERACTING PROTEIN,SSTRIP; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SHANK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN PROTEIN INTERACTIONS, PDZ DOMAIN, HYBRID STRUCTURES, KEYWDS 2 FRAGMENT-BASED DRUG DISCOVERY, BETA-SHEETS ACYLHYDRAZONE, PEPTIDE KEYWDS 3 BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.HEGEDUS,F.HOBOR,D.K.SHOEMARK,S.CELIS,L.J.LIAN,C.H.TRINH, AUTHOR 2 R.B.SESSIONS,T.A.EDWARDS,A.J.WILSON REVDAT 3 24-JAN-24 6YX1 1 REMARK REVDAT 2 07-JUL-21 6YX1 1 JRNL REVDAT 1 20-JAN-21 6YX1 0 JRNL AUTH Z.HEGEDUS,F.HOBOR,D.K.SHOEMARK,S.CELIS,L.Y.LIAN,C.H.TRINH, JRNL AUTH 2 R.B.SESSIONS,T.A.EDWARDS,A.J.WILSON JRNL TITL IDENTIFICATION OF BETA-STRAND MEDIATED PROTEIN-PROTEIN JRNL TITL 2 INTERACTION INHIBITORS USING LIGAND-DIRECTED FRAGMENT JRNL TITL 3 LIGATION. JRNL REF CHEM SCI V. 12 2286 2021 JRNL REFN ISSN 2041-6520 JRNL PMID 34163995 JRNL DOI 10.1039/D0SC05694D REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0026 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 22226 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.610 REMARK 3 FREE R VALUE TEST SET COUNT : 1914 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1045 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 99 REMARK 3 BIN FREE R VALUE : 0.2816 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1614 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.77 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.200 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.11 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YX1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107816. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO, AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23326 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.708 REMARK 200 RESOLUTION RANGE LOW (A) : 52.232 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.9 REMARK 200 DATA REDUNDANCY : 12.30 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.83800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1Q3O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES 7.75 PEG 400 40% 30% W/V REMARK 280 TRIMETHYLAMINE N-OXIDE DIHYDRATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.33400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.81850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.95600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.81850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.33400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.95600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 682 REMARK 465 ALA A 683 REMARK 465 GLN A 684 REMARK 465 THR A 685 REMARK 465 PRO A 686 REMARK 465 ILE A 687 REMARK 465 GLU A 688 REMARK 465 HIS A 759 REMARK 465 PRO A 760 REMARK 465 ASP A 761 REMARK 465 MET A 762 REMARK 465 PRO B 760 REMARK 465 ASP B 761 REMARK 465 MET B 762 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 758 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 688 O HOH B 901 2.13 REMARK 500 O HOH B 953 O HOH B 958 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 671 36.24 -88.98 REMARK 500 SER B 671 33.04 -87.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 THR A 802 REMARK 610 ARG A 803 REMARK 610 THR B 802 REMARK 610 ARG B 803 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ARG A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LEU A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ARG B 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LEU B 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PWT A 801 and THR A REMARK 800 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PWT B 801 and THR B REMARK 800 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6YWZ RELATED DB: PDB REMARK 900 RELATED ID: 6YX0 RELATED DB: PDB REMARK 900 RELATED ID: 6YX2 RELATED DB: PDB DBREF 6YX1 A 654 762 UNP Q9Y566 SHAN1_HUMAN 654 762 DBREF 6YX1 B 654 762 UNP Q9Y566 SHAN1_HUMAN 654 762 SEQADV 6YX1 GLY A 651 UNP Q9Y566 EXPRESSION TAG SEQADV 6YX1 PRO A 652 UNP Q9Y566 EXPRESSION TAG SEQADV 6YX1 LEU A 653 UNP Q9Y566 EXPRESSION TAG SEQADV 6YX1 GLY B 651 UNP Q9Y566 EXPRESSION TAG SEQADV 6YX1 PRO B 652 UNP Q9Y566 EXPRESSION TAG SEQADV 6YX1 LEU B 653 UNP Q9Y566 EXPRESSION TAG SEQRES 1 A 112 GLY PRO LEU GLY SER ASP TYR ILE ILE LYS GLU LYS THR SEQRES 2 A 112 VAL LEU LEU GLN LYS LYS ASP SER GLU GLY PHE GLY PHE SEQRES 3 A 112 VAL LEU ARG GLY ALA LYS ALA GLN THR PRO ILE GLU GLU SEQRES 4 A 112 PHE THR PRO THR PRO ALA PHE PRO ALA LEU GLN TYR LEU SEQRES 5 A 112 GLU SER VAL ASP GLU GLY GLY VAL ALA TRP ARG ALA GLY SEQRES 6 A 112 LEU ARG MET GLY ASP PHE LEU ILE GLU VAL ASN GLY GLN SEQRES 7 A 112 ASN VAL VAL LYS VAL GLY HIS ARG GLN VAL VAL ASN MET SEQRES 8 A 112 ILE ARG GLN GLY GLY ASN THR LEU MET VAL LYS VAL VAL SEQRES 9 A 112 MET VAL THR ARG HIS PRO ASP MET SEQRES 1 B 112 GLY PRO LEU GLY SER ASP TYR ILE ILE LYS GLU LYS THR SEQRES 2 B 112 VAL LEU LEU GLN LYS LYS ASP SER GLU GLY PHE GLY PHE SEQRES 3 B 112 VAL LEU ARG GLY ALA LYS ALA GLN THR PRO ILE GLU GLU SEQRES 4 B 112 PHE THR PRO THR PRO ALA PHE PRO ALA LEU GLN TYR LEU SEQRES 5 B 112 GLU SER VAL ASP GLU GLY GLY VAL ALA TRP ARG ALA GLY SEQRES 6 B 112 LEU ARG MET GLY ASP PHE LEU ILE GLU VAL ASN GLY GLN SEQRES 7 B 112 ASN VAL VAL LYS VAL GLY HIS ARG GLN VAL VAL ASN MET SEQRES 8 B 112 ILE ARG GLN GLY GLY ASN THR LEU MET VAL LYS VAL VAL SEQRES 9 B 112 MET VAL THR ARG HIS PRO ASP MET HET PWT A 801 19 HET THR A 802 7 HET ARG A 803 11 HET LEU A 804 9 HET PWT B 801 19 HET THR B 802 7 HET ARG B 803 11 HET LEU B 804 9 HETNAM PWT 2-[[2-(5-OXIDANYLIDENEPENTANOYL) HETNAM 2 PWT HYDRAZINYL]METHYL]BENZOIC ACID HETNAM THR THREONINE HETNAM ARG ARGININE HETNAM LEU LEUCINE FORMUL 3 PWT 2(C13 H16 N2 O4) FORMUL 4 THR 2(C4 H9 N O3) FORMUL 5 ARG 2(C6 H15 N4 O2 1+) FORMUL 6 LEU 2(C6 H13 N O2) FORMUL 11 HOH *113(H2 O) HELIX 1 AA1 GLY A 709 GLY A 715 1 7 HELIX 2 AA2 GLY A 734 GLY A 745 1 12 HELIX 3 AA3 GLY B 709 GLY B 715 1 7 HELIX 4 AA4 GLY B 734 GLY B 745 1 12 SHEET 1 AA1 8 GLN A 728 ASN A 729 0 SHEET 2 AA1 8 PHE A 721 VAL A 725 -1 N VAL A 725 O GLN A 728 SHEET 3 AA1 8 THR A 748 THR A 757 -1 O VAL A 754 N PHE A 721 SHEET 4 AA1 8 ASP A 656 GLN A 667 -1 N LEU A 666 O LEU A 749 SHEET 5 AA1 8 ASP B 656 GLN B 667 -1 O TYR B 657 N ILE A 659 SHEET 6 AA1 8 THR B 748 ARG B 758 -1 O LEU B 749 N LEU B 666 SHEET 7 AA1 8 PHE B 721 VAL B 725 -1 N PHE B 721 O VAL B 754 SHEET 8 AA1 8 GLN B 728 ASN B 729 -1 O GLN B 728 N VAL B 725 SHEET 1 AA2 2 PHE A 676 GLY A 680 0 SHEET 2 AA2 2 GLN A 700 VAL A 705 -1 O TYR A 701 N ARG A 679 SHEET 1 AA3 2 PHE B 676 GLY B 680 0 SHEET 2 AA3 2 GLN B 700 VAL B 705 -1 O TYR B 701 N ARG B 679 LINK C14 PWT A 801 N THR A 802 1555 1555 1.33 LINK C14 PWT B 801 N THR B 802 1555 1555 1.34 SITE 1 AC1 6 PHE A 676 VAL A 677 ASP A 706 THR A 802 SITE 2 AC1 6 LEU A 804 HOH A 925 SITE 1 AC2 7 GLY A 673 PHE A 674 GLY A 675 PHE A 676 SITE 2 AC2 7 ILE A 742 ARG A 803 HOH A 925 SITE 1 AC3 4 VAL B 677 ASP B 706 THR B 802 LEU B 804 SITE 1 AC4 7 GLY B 673 PHE B 674 GLY B 675 PHE B 676 SITE 2 AC4 7 ILE B 742 THR B 802 ARG B 803 SITE 1 AC5 6 VAL A 677 LEU A 678 GLY A 680 HIS A 735 SITE 2 AC5 6 ARG A 736 ARG A 803 SITE 1 AC6 10 VAL B 677 LEU B 678 ARG B 679 GLY B 680 SITE 2 AC6 10 HIS B 735 ARG B 736 ARG B 803 LEU B 804 SITE 3 AC6 10 HOH B 904 HOH B 942 CRYST1 44.668 65.912 85.637 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022387 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015172 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011677 0.00000